.jpeg)
Is Dabrafenib a BRAF inhibitor?
Yes. The combination of BRAF inhibitor dabrafenib and MEK inhibitor trametinib has transformed the practice of treating BRAF V600-mutant cancers. Dabrafenib is indicated as a single agent for the treatment of BRAF V600E mutation-positive unresectable or metastatic melanoma. Dabrafenib in combination with trametinib: for BRAF V600E or V600K mutation-positive unresectable or metastatic melanoma; for BRAF V600EorV600KAdjuvant treatment of mutation-positive melanoma; for BRAF BRAF Patients with V600Emutant solid tumors. If you want to get more high-quality information, you can contact Yaode. Yade will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
